Google DeepMind Unveils AlphaFold 3
Google DeepMind has unveiled the third major version of its artificial intelligence model «AlphaFold», designed to assist scientists in searching for drugs and fighting diseases, RBC-Ukraine reports, citing Reuters.
Advancements in Molecular Biology
In 2020, the company made significant progress in molecular biology, using AI to successfully predict the behavior of microscopic proteins.
Studying Life Molecules
The latest iteration of AlphaFold has allowed researchers from DeepMind and their subsidiary Isomorphic Labs, led by co-founder Demis Hassabis, to study the behavior of all life molecules, including human DNA.
Accelerating Treatment Development
DeepMind claims that the new AI will help reduce the time and money required to develop treatment methods that can change lives. «With these new capabilities, we can create a molecule that will bind to a specific spot on a protein, and predict how strongly it will bind,» said Hassabis.
AlphaFold Server Tool
The company has also announced the release of a free online tool called «AlphaFold server», which allows scientists to test their hypotheses before conducting real-world experiments. DeepMind stated that the new server is user-friendly, allowing researchers to run tests with just a few clicks.
Impact on Drug Discovery
Dr. Nicole Wheeler, a microbiology expert from the University of Birmingham, noted that AlphaFold 3 could significantly accelerate the drug discovery process.
